CornerCube is a Netherlands-based developer of precision prism solutions for the geodesy and land surveying sector.

The company occupies a deliberate position in the market: between the high cost of traditional professional prisms and the compromised accuracy of reflective stickers. CornerCube's products are engineered to deliver the precision of high-quality optical instruments at a price point that makes them practical for everyday site use

University of Florence researchers use Henniker’s HPT-100 to develop a microfluidic biosensor for non-invasive Parkinson’s disease drug monitoring.

Enabling New Insights into Nanoscale Surface Chemistry

Gold nanoparticles (AuNPs) are essential components in modern healthcare diagnostics, plasmonic sensing, catalysis, and nanomaterial design. Their performance depends critically on surface chemistry — how ligands, ions, and trace species interact at the nanoscale interface. Even subtle changes in the interfacial environment can reshape morphology, alter molecular binding, and ultimately determine material functionality. Understanding these dynamic surface processes is therefore fundamental to designing better sensors, catalysts, and nanomaterials.

Cells migrate in response to environmental gradients as part of development, immune response, wound healing, and disease progression. For decades, the prevailing understanding has been that cell migration towards stiffer substrates (a process called durotaxis) depends critically on focal adhesions. These molecular anchors sense substrate stiffness and transmit forces that guide directed cell motion. However, recent research reveals a fundamentally different migration mechanism that operates without focal adhesions entirely.

The Medical Device Manufacturing Centre (MDMC), based in Scotland, acts as a strategic partner for SMEs, university spinouts, and researchers seeking to bridge the gap between early-stage innovation and commercial success.

Since its launch in 2020, MDMC has worked with over 170 companies and entrepreneurs, guiding them through prototyping, small-batch production, and the full regulatory landscape (UKCA and CE marking) that governs the path to market for medical devices.

Retinal organoids are tiny 3D models of retinal tissue used in medical and life-science research and are changing how scientists explore eye disease, develop therapies, and evaluate new drugs. However, one persistent challenge has been their unreliable interaction with biomaterial surfaces. Poor attachment or inconsistent cell development limits experimental accuracy and slows progress in regenerative medicine.

November 2025 – Henniker, UK.

Henniker Plasma, the UK’s leading manufacturer of plasma treatment systems, has announced the launch of Nova, a new advanced benchtop plasma system that brings industrial-grade process control to the research and development environment.

January 2026 – Henniker, UK.

Henniker Plasma announces the launch of CoatX®, an advanced plasma-coating technology designed to deliver permanent, nano-scale functional coatings that transform surface performance without altering the underlying material.

In a recent article published in the journal iScience, researchers at UCLA have found that cells can repair themselves in seconds after being gently squeezed to let in genetic material. This researchcould help make future gene therapies safer, more efficient, and more economical.

The article “Development of Antibacterial Cotton-Black Viscose and Cotton-Polyester Blended-Knit Fabric Using Ag Doped ZnO Nanocomposite”, published in Advanced Materials Interfaces by the research group of Professor Tanu Arefin, explores how plasma treatment enhances the development of antibacterial knit fabrics using silver-doped zinc oxide nanocomposites. The research focuses on cotton–polyester and cotton–black viscose blends, aiming to improve hygiene, comfort and durability without compromising the natural softness of the textiles.

Meet Henniker Plasma at Microscopy Conference 2025, Karlsruhe

Event Overview

We’re excited to announce that Henniker Plasma will be exhibiting at the Microscopy Conference 2025 (MC2025) in Karlsruhe, taking place from 31st August – 4th September 2025.

Oxygen Plasma Activation with HPT-100 for Stronger Silicon Carbide Joints

A recent study by researchers at The University of Virginia, in collaboration with Ceramic Tubular Products LLC, has demonstrated thatoxygen plasma activation, performed using the Henniker HPT-100 plasma cleaner, can significantly improve the joining ofsilicon carbide (SiC) components. By modifying the SiC surface prior to pressure-less brazing with a silica–alumina–magnesia (SAMg) glass filler, researchers achieved stronger, fully hermetic joints - with over150% higher strength than untreated samples.

July 2025 – Henniker, UK — Henniker Plasma, a leading manufacturer of plasma treatment systems, announces the launch of itsStratus Plasma Manufacturing Cell range — a fully integrated, turnkey solution that combines advanced atmospheric plasma surface preparation with robotic automation.